IFI-M · HB Tissue-Specific Series

Specimen SS-F-M2-01698 // MULTI-AXIS · IFI-M

HB Tissue-Specific Series II-BL-C

Capsicum chinense

Habanero

Tier IIHB Tissue-Specific Series

Target Trait

1.9×

fold-change

Heat+Bitter-Attenuation tissue-specific dual expression

Technical Specifications

SKU

SS-F-M2-01698

Genomic Edits

7

GC Content

44.9%

Construct Length

3,988 bp

Promoter System

CaMV 35S / Ubiquitin

Expression System

Biolistic transformation

Host Strain

Particle Gun

Receptor Target

TRPV1 + TAS2R38 (suppression)

IFI Score

190

Pathway Edits

  • TRPV1 pathway primary gene cluster overexpression for heat axis activation
  • TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
  • Bidirectional promoter system for synchronized H+B dual-axis co-expression
  • Metabolic flux partitioning between IFI-H and IFI-B pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Heat-Bitter-Attenuation combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for H+B simultaneous accumulation
  • Tissue-specific expression cassette deployment for optimized HB spatial patterning

Key Interventions

Dual-receptor co-activation via synchronized TRPV1 and TAS2R38 (suppression) pathway engineeringMetabolic flux partitioning strategy enabling simultaneous heat and bitter-attenuation accumulation without competing pathway suppressionTissue-specific dual expression for HB multi-axis integrationBiolistic co-bombardment of multi-axis transgene cassettes for high-copy integration events

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier II HB dual-axis tissue-specific platform for food ingredient applications requiring verified combined heat+bitter-attenuation sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$849 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities